Latest filing published 18 Sept 2024 for G1 Therapeutics, Inc.. Read the official filing
No signal scores available.
All filings by Monica R. Thomas on record concern G1 Therapeutics, Inc. We count 6 filings; the first trade dates from 22 May 2023 and the latest from 18 September 2024.
The open-market record consists of 1 sale worth €23k, with no purchase. Besides market trades, the filings include 4 share grants. 2024 to date brings no purchases and 1 sale.
The latest filing, published on 18 September 2024, reports a transaction in G1 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations